Stanley C. Erck, Director at MAXCYTE, INC. (MXCT), sold 95,378 shares at $3.72 ($355K) on 2024-11-01, disclosed to the SEC on 2024-11-05.
Scheduled sale ($355k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.72 | 47,689 | $177K | 50.0% |
| 2 | $3.72 | 47,689 | $177K | 50.0% |
| Total | $3.72 avg | 95,378 | $355K | 100% |
| Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |
| NVAX | SELL | 2021-10-05 | $12.4M | — | Filing → |